Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy
Ya Chu Tang
, Yung Jen Chuang
, Hsin Huei Chang
, Shin Hun Juang
, Gow Chin Yen
,
Jang Yang Chang
, Ching Chuan Kuo
Taipei Medical University Hospital
TMU Research Center of Cancer Translational Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Therapy
100%
Transcription Factor Nrf2
100%
Chemoprophylaxis
100%
Cancer Cell
30%
Malignant Neoplasm
20%
Cytoprotective Agent
20%
Antioxidant
10%
Carcinogenesis
10%
Gene Expression
10%
Carcinogen
10%
Tumor Progression
10%
Phytochemical
10%
Chemoprevention
10%
Electrophile
10%
Drug Resistance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Transcription Factor Nrf2
100%
Cytoprotective Agent
20%
Phytochemical
10%
Tumor Growth
10%
Carcinogen
10%
Electrophile
10%
Antioxidant
10%
Drug Resistance
10%
Carcinogenesis
10%